Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (41-50 of 373) with videos related to

Pageof 38
Sort By:
Blood|January 26, 2022
Three US Food and Drug Administration-approved therapies for chronic GVHDRobert Zeiser, Stephanie J Lee
Cell Chemical Biology|January 16, 2026
Cutting without cleaving: How caspase-1 shapes leukemia beyond enzymatic activityLukas M Braun, Robert Zeiser
The New England Journal of Medicine|December 28, 2017
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic TargetsRobert Zeiser, Bruce R Blazar
Blood|November 9, 2016
Introduction to a review series on chronic GVHD: from pathogenic B-cell receptor signaling to novel therapeutic targetsRobert Zeiser, Robert S Negrin
Hemasphere|June 7, 2021
Immunomodulatory Therapies for the Treatment of Graft-versus-host DiseaseLukas M Braun, Robert Zeiser
Frontiers in Immunology|December 6, 2021
Kinase Inhibition as Treatment for Acute and Chronic Graft-<i>Versus</i>-Host DiseaseLukas M Braun, Robert Zeiser
Frontiers in Immunology|October 25, 2021
Acute Graft-<i>Versus</i>-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous SystemJanaki Manoja Vinnakota, Robert Zeiser
Blood|January 9, 2025
FDA-approved therapies for chronic GVHDStephanie J Lee, Robert Zeiser
The New England Journal of Medicine|February 8, 2018
Acute Graft-versus-Host DiseaseRobert Zeiser, Bruce R Blazar
The New England Journal of Medicine|November 25, 2017
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and TherapyRobert Zeiser, Bruce R Blazar
Pageof 38

Showing results (41-50 of 373) with videos related to

Sort By:
Pageof 38
Blood|January 26, 2022
Three US Food and Drug Administration-approved therapies for chronic GVHDRobert Zeiser, Stephanie J Lee
Cell Chemical Biology|January 16, 2026
Cutting without cleaving: How caspase-1 shapes leukemia beyond enzymatic activityLukas M Braun, Robert Zeiser
The New England Journal of Medicine|December 28, 2017
Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic TargetsRobert Zeiser, Bruce R Blazar
Blood|November 9, 2016
Introduction to a review series on chronic GVHD: from pathogenic B-cell receptor signaling to novel therapeutic targetsRobert Zeiser, Robert S Negrin
Hemasphere|June 7, 2021
Immunomodulatory Therapies for the Treatment of Graft-versus-host DiseaseLukas M Braun, Robert Zeiser
Frontiers in Immunology|December 6, 2021
Kinase Inhibition as Treatment for Acute and Chronic Graft-<i>Versus</i>-Host DiseaseLukas M Braun, Robert Zeiser
Frontiers in Immunology|October 25, 2021
Acute Graft-<i>Versus</i>-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous SystemJanaki Manoja Vinnakota, Robert Zeiser
Blood|January 9, 2025
FDA-approved therapies for chronic GVHDStephanie J Lee, Robert Zeiser
The New England Journal of Medicine|February 8, 2018
Acute Graft-versus-Host DiseaseRobert Zeiser, Bruce R Blazar
The New England Journal of Medicine|November 25, 2017
Acute Graft-versus-Host Disease - Biologic Process, Prevention, and TherapyRobert Zeiser, Bruce R Blazar
Pageof 38